Omics, MDx Stocks Rise 5 Percent in June Led by Exact Sciences, Sequenom, PacBio, and GenMark | GenomeWeb

NEW YORK (GenomeWeb) – After a mixed picture in May, shares of firms in the omics research tools and MDx space rebounded in June as the GenomeWeb Daily News Index improved by more than 5 percent month over month.

Exact Sciences (+26 percent) paced the gainers, followed by Sequenom (+26 percent), Pacific Biosciences (+25 percent), and GenMark Diagnostics (+23 percent).

Vermillion (-4 percent) and CombiMatrix (-4 percent) were the biggest decliners in June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.